-Reuters
Related Posts
Xylem Q2 EPS $0.66 Beats $0.54 Estimate, Sales $1.40B Beat $1.31B Estimate
Xylem (NYSE:XYL) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.54 by 22.22 percent. This is unchanged from the same period last year. The company reported quarterly sales
Senior Adviser to Iran’s Khamenei Said Tehran is Technically Capable of Producing Nuclear Bomb; Said Tehran Will Directly Respond Against Israel Should Its Security Be Targeted
- Al Jazeera
https://www.aljazeera.net/news/politics/2022/7/17/%d8%b9%d8%a7%d8%ac%d9%84-%d9%83%d9%85%d8%a7%d9%84-%d8%ae%d8%b1%d8%a7%d8%b2%d9%8a-%d9%84%d9%84%d8%ac%d8%b2%d9%8a%d8%b1%d8%a9-%d9%84%d9%8a%d8%b3-%d8%b3%d8%b1%d8%a7-%d8%a3%d9%86
